Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Trenbolone undecanoate
Clinical data | |
---|---|
Other names | Trenbolone undecylate; Estra-4,9,11-trien-17β-ol-3-one 17β-undecylate |
Routes of administration |
Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester; Progestogen |
Identifiers | |
| |
Chemical and physical data | |
Formula | C29H41O3 |
Molar mass | 437.644 g·mol−1 |
3D model (JSmol) | |
| |
|
Trenbolone undecanoate, or trenbolone undecylate, is a synthetic and injected anabolic–androgenic steroid (AAS) and a derivative of nandrolone (19-nortestosterone) which was never marketed. It is the C17β undecanoate (undecylate) ester and a long-acting prodrug of trenbolone. The drug was described by Roussel Uclaf in 1967 and was the first long-lasting ester of trenbolone to be developed. Subsequently, trenbolone hexahydrobenzylcarbonate, a roughly equivalent compound, was developed and introduced for use in humans in 1980, though it was discontinued in 1997.Trenbolone enanthate is another long-lasting ester of trenbolone. Similarly to trenbolone undecanoate, it was never marketed, but it has been sold on the black market as a designer steroid for bodybuilders and athletes.
See also
Further reading
- Yarrow JF, McCoy SC, Borst SE (2010). "Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity". Steroids. 75 (6): 377–89. doi:10.1016/j.steroids.2010.01.019. PMID 20138077. S2CID 205253265.
PR |
|
||||||
---|---|---|---|---|---|---|---|
mPR (PAQR) |
|
||||||